Noble Dragons: Lab Test Results
Independent Certificates of Analysis aggregated from public lab results. Not affiliated with or paid by Noble Dragons.
113
CoAs on file
99.63%
Avg reported purity
42
Compounds tested
Sep 24, 2026
Latest test
Results by compound
| Compound | CoAs | Avg purity | Latest |
|---|---|---|---|
| Retatrutide | 27 | 99.67% | Sep 24, 2026 |
| Tirzepatide | 16 | 99.8% | Aug 5, 2026 |
| MOTS-C | 8 | 99.42% | Apr 10, 2026 |
| BPC-157 | 5 | 99.81% | Apr 22, 2026 |
| GHK-Cu | 5 | 99.52% | Feb 13, 2026 |
| Tesamorelin | 4 | 99.3% | May 4, 2026 |
| NAD+ | 4 | n/a | Apr 2, 2026 |
| SS-31 | 3 | 99.36% | Feb 12, 2026 |
| Semaglutide | 3 | 99.59% | Feb 13, 2026 |
| Klow | 2 | n/a | Nov 21, 2025 |
| KPV | 2 | 99.23% | Mar 16, 2026 |
| Cagrilintide | 2 | n/a | |
| CND10 | 2 | 99.75% | Mar 12, 2026 |
| ET50 | 2 | 99.49% | Mar 16, 2026 |
| LL37 | 1 | 99.54% | Mar 16, 2026 |
| GHK-Cu, BPC-157, TB-500 | 1 | n/a | Mar 30, 2026 |
| Klow 80mg Pink | 1 | n/a | Nov 4, 2025 |
| Epitalon | 1 | 99.49% | Mar 16, 2026 |
| TB-500 | 1 | 99.91% | Apr 10, 2026 |
| GHK-Cu, TB-500, BPC-157 | 1 | n/a | Nov 3, 2025 |
| KS10 | 1 | 99.44% | Mar 12, 2026 |
| LL-37 | 1 | 99.54% | Mar 16, 2026 |
| Selank | 1 | 99.96% | Aug 1, 2025 |
| KLOW | 1 | n/a | Apr 21, 2026 |
| Melanotan | 1 | 99.42% | Mar 12, 2026 |
| PT-141 | 1 | 99.91% | Feb 9, 2026 |
| Kisspeptin-10 | 1 | 99.44% | Mar 12, 2026 |
| BPC-157, GHK-Cu, TB-500, KPV | 1 | n/a | Nov 3, 2025 |
| BPC-157, TB-500 | 1 | n/a | Feb 13, 2026 |
| Melanotan II | 1 | 99.74% | Mar 16, 2026 |
Top 30 of 42 compounds shown.
Recent CoAs
| Compound | Batch | Purity | Lab | Tested | |
|---|---|---|---|---|---|
| Retatrutide | ND-TITAN-RT10-WHITE-060726 | n/a | Lab E | Sep 24, 2026 | verify |
| Retatrutide | RET-26031501 | n/a | Lab G | Sep 7, 2026 | verify |
| Retatrutide | ND-TITAN-RT10-WHITE-060726 | n/a | Lab E | Aug 26, 2026 | verify |
| Tirzepatide | 003-30T-HJH | 99.9% | Lab E | Aug 5, 2026 | verify |
| Retatrutide | n/a | n/a | Lab G | Jun 12, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Jun 12, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Jun 1, 2026 | verify |
| Tesamorelin | TSM10 | 99.155% | Janoshik | May 4, 2026 | verify |
| Tesamorelin | TSM10 | 99.372% | Janoshik | Apr 29, 2026 | verify |
| Tirzepatide | n/a | 99.9% | Lab E | Apr 28, 2026 | verify |
| BPC-157 | BC10 | 99.784% | Janoshik | Apr 22, 2026 | verify |
| Tirzepatide | TR30 | 99.928% | Janoshik | Apr 22, 2026 | verify |
| KLOW | KL80 | n/a | Janoshik | Apr 21, 2026 | verify |
| BPC-157 + TB-500 | BB10 | n/a | Janoshik | Apr 21, 2026 | verify |
| Retatrutide | RT10 | 99.87% | Janoshik | Apr 20, 2026 | verify |
| BPC-157 | BC10 | 99.734% | Janoshik | Apr 10, 2026 | verify |
| TB-500 | BT10 | 99.907% | Janoshik | Apr 10, 2026 | verify |
| MOTS-C | MS10 | 99.055% | Janoshik | Apr 10, 2026 | verify |
| BPC-157 | BC10 | 99.734% | Janoshik | Apr 10, 2026 | verify |
| Retatrutide | RT30 | 99.707% | Janoshik | Apr 10, 2026 | verify |
| AICAR | AR50 | 98.58% | Janoshik | Apr 9, 2026 | verify |
| NAD+ | NJ500 | n/a | Janoshik | Apr 2, 2026 | verify |
| Retatrutide | RT20 | 99.88% | Janoshik | Apr 1, 2026 | verify |
| GHK-Cu, BPC-157, TB-500 | Glow70260320 | n/a | Janoshik | Mar 30, 2026 | verify |
| Retatrutide | n/a | 99.9% | Lab E | Mar 18, 2026 | verify |
Showing 25 most recent of 113. Search the full database on the CoA page.
Embed this badge
Sell or represent Noble Dragons? Link your customers to this page with the badge below. Free, no signup. The badge and counts update as new lab results land.
<a href="https://ascendpeptide.org/coa/vendor/noble-dragons/" rel="noopener"> <img src="https://ascendpeptide.org/coa/badge/noble-dragons.svg" alt="Noble Dragons: lab tested, 113 CoAs on file at ASCEND Peptide" width="230" height="54"> </a>
Data comes from publicly posted third-party lab certificates (Janoshik, MZ Biolabs, and others) and community submissions. Purity figures are as reported by the testing lab for the specific batch tested; they are not a guarantee of any other batch. For research and informational purposes only.